metastatic/adv melanoma (mML) | |||
mML - L1 - all population | mML - L1 - BRAF mutant | mML - L1 - BRAF wild | |
nivolumab plus ipilimumab | CheckMate 067 ... CheckMate 069 ... CheckMate 067 ... | CheckMate 069 ... | CheckMate 069 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -